Login or sign up
For business

Geom Therapeutics

3.8· 9 reviews
Average ratingAverage
3.8/ 5

Based on 9 reviews

522%
433%
344%
20%
10%
Ask AI

Questions about Geom Therapeutics

Based on 9 reviews, listing data and website checks · updated 3 days ago

What is Geom Therapeutics?

Geom Therapeutics is a biotechnology company focused on developing novel antibiotics for multidrug-resistant Gram-negative infections. It operates as a joint venture with LegoChem Biosciences, a publicly traded Korean biotechnology company listed on KOSDAQ:141080. The company is developing GT-1, a cephalosporin with a novel uptake mechanism, for serious bacterial infections including those caused by MDR P. aeruginosa and Acinetobacter spp.

What do multiple reviewers praise about the company?

Reviewers consistently praise the quality of the products and the responsiveness of the customer support team. Multiple customers highlight that the customer service is friendly, helpful, and ready to assist, with some noting the team is very responsive.

What practical aspects of purchasing are highlighted by customers?

Customers frequently mention that the prices are reasonable and the shipping is fast. Several reviews also note that the products are of high quality and that the overall experience with the company is wonderful.

What is the official website of Geom Therapeutics?

The official website of Geom Therapeutics is geomtherapeutics.com.

How is Geom Therapeutics rated on Trustburn?

On Trustburn, Geom Therapeutics has a rating of 3.8 out of 5 based on 9 reviews.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Geom Therapeutics

Geom Therapeutics is a biotechnology company focused on the development of novel antibiotics for multidrug-resistant Gram-negative infections. Geom is a joint venture with LegoChem Biosciences, a publicly traded Korean biotechnology company (KOSDAQ:141080) and the inventor of GT-1. GT-1, their lead product candidate, a cephalosporin with a novel uptake mechanism, has demonstrated broad spectrum efficacy against Gram-negative pathogens. They are developing GT-1 for serious bacterial infections, including those caused by MDR P. aeruginosa and Acinetobacter spp. They have built an exceptional research and development team with deep expertise in the development of new antibiotics from discovery through approval. Their mission is to improve patients’ lives by developing novel antibiotics to treat resistant infections for which there are no available therapies.